Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy

NCT01434147 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

NETWORK

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: preoperative induction chemotherapy in combination with bevacizumab followed by combined radiochemotherapy with capecitabine

Sponsor

Austrian Breast & Colorectal Cancer Study Group

Collaborators

[object Object]